- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 388
Rare drug spin-off Vtesse raises $25m
Vtesse, which has spun-off from accelerator Cydan Development, secured the funding from backers including Pfizer and Lundbeck.
Jan 8, 2015Tencent draws Line0 to $30m series B
Food delivery service Line0 has closed a series B round led by internet portal Tencent, and will use the funds to expand within China.
Jan 8, 2015Stem to grow with $27m series C
The energy optimisation company has added Exelon and Total to an investor base already containing General Electric and Iberdrola.
Jan 8, 2015CytomX activates $20m series C
Pfizer led the Roche-backed antibody developer's series C round, which boosted its overall funding to $66m.
Jan 7, 2015Chiasma recovers to secure $33.8m
Following a cancelled deal with pharmaceutical company Roche, the Ofer-backed pharmaceutical company has raised the first tranche of a planned $56.3m series E round.
Jan 7, 2015View opens up for $75m round
The GE and Corning-backed energy-efficient window manufacturer has raised almost $29m of a $75m late-stage equity round.
Jan 7, 2015Chiasma recovers to secure $33.8m
Following a cancelled deal with pharmaceutical company Roche, the Ofer-backed pharmaceutical company has raised the first tranche of a planned $56.3m series E round.
Jan 6, 2015IDG finds Valyoo in India
IDG Ventures India has participated in a $21.3m series C round that valued the e-commerce company at $100m.
Jan 5, 2015Intel eyes Vuzix investment
Intel has invested $24.8m in publicly-listed video eyewear and smart glasses developer Vuzix.
Jan 5, 2015About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


